Overview of Argus Cognitive
Argus Cognitive is a purpose-driven healthcare startup dedicated to solving some of the most urgent challenges in child behavioral health. We develop AI-enabled tools that bring objectivity, scalability, and early intervention to conditions like autism spectrum disorder (ASD). Our team combines expertise in artificial intelligence, clinical research, and regulatory science to build medical-grade technologies that improve diagnostic accuracy, enhance therapeutic monitoring, and reduce disparities in access to care. Our lead product, Neurora, exemplifies our commitment to transforming how neurodevelopmental conditions are identified and managed – making earlier, more effective support possible for children and families around the world.
Our Ask
We are seeking philanthropic partnerships and funding opportunities to accelerate the adoption and accessibility of Neurora, our non-invasive, AI-enabled diagnostic and therapy-monitoring tool for autism spectrum disorder (ASD). Specifically, we aim to expand clinical deployment, support regulatory milestones, identify new sources of capital, and enhance our research collaborations with institutions serving neurodiverse populations.
Product or Service
Neurora is a Software as a Medical Device (SaMD) that supports both early diagnosis and ongoing monitoring of autism spectrum disorder (ASD) in toddlers and children. The multimodal system uses advanced machine learning to analyze behavioral data to generate psychometric reports. These reports provide clinicians with objective, quantitative insights into social behaviors, enhancing diagnostic accuracy and enabling timely, personalized therapeutic interventions.
Company Impact
Argus Cognitive addresses long-standing challenges in autism care by introducing precision, objectivity, and accessibility into the diagnostic and therapeutic process. Our approach enables earlier identification of ASD, reduces disparities in care, and allows clinicians to monitor therapeutic response over short intervals—something previously out of reach for most health systems. By bridging clinical practice and data science, we aim to set a new standard in behavioral health diagnostics.
Primary Audience
The primary beneficiaries of Neurora are toddlers and children presenting with signs of autism spectrum disorder (ASD) or related neurodevelopmental conditions, along with the healthcare professionals responsible for their diagnosis and ongoing care. Additional stakeholders include caregivers seeking clarity and support, clinical researchers studying early childhood development, and therapy providers who require data-driven tools to monitor progress and tailor interventions.
Partnership Opportunity
We are actively exploring partnerships with:
- Philanthropic foundations focused on early childhood development, neurodiversity, or healthcare equity
- Clinics and health systems serving under-resourced populations
- Academic and research institutions advancing autism diagnostics and intervention science
- Advocacy organizations looking to improve access, reduce disparities, and drive policy around autism care
- Technology partners to support scaling, deployment, and infrastructure
We welcome opportunities to co-develop community-based programs, expand access to early diagnosis, and support research that informs policy and systemic change.